CCLG Research Talks: How biobanking supports childhood cancer research
Hear from Dr John Moppett about what the VIVO biobank is and how it supports expert childhood cancer research.
Hear from Dr John Moppett about what the VIVO biobank is and how it supports expert childhood cancer research.
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to Cambridge to find out...
Childhood cancer researchers looking at the composition of a childhood brain tumour called ependymoma have made a key breakthrough in the way this disease is understood. For years, treatments for ependymoma have seen limited progress, with no major breakthroughs on the horizon for these young...
Children's Cancer and Leukaemia Group (CCLG) has partnered with Young Lives vs Cancer to fund a new research project that will assess the benefits and challenges of administering chemotherapy at home to children with cancer. The goal of this jointly funded project is to understand more...
New research into a rare type of leukaemia has been funded, thanks to several Children's Cancer and Leukaemia Group (CCLG) Special Named Funds.
Only 32% of adult survey respondents felt confident in recognising cancer signs and symptoms in children, teenagers and young adults, according to newly published research.
Cancer cells can have differences in how they survive, respond to treatment, and behave. This variability can help cancer cells survive and adapt, but it also makes doctors’ jobs much harder.
Not only do children get different types of cancer, but there are also big differences in the treatment, diagnosis, and causes of their cancer. Find out more about these differences...
Children’s Cancer and Leukaemia Group (CCLG) hosted its inaugural Research Discovery Day last week (20 September), to offer valuable insight into the research it funds to families and supporters.